Asunto(s)
Anestesiología/organización & administración , COVID-19/epidemiología , Encuestas de Atención de la Salud/estadística & datos numéricos , Pandemias , SARS-CoV-2 , Anestesiólogos/organización & administración , Anestesiología/estadística & datos numéricos , Reconversión de Camas/estadística & datos numéricos , COVID-19/terapia , Análisis Costo-Beneficio , Cuidados Críticos/estadística & datos numéricos , Capacidad de Camas en Hospitales/estadística & datos numéricos , Humanos , Unidades de Cuidados Intensivos , Admisión y Programación de Personal , España/epidemiologíaRESUMEN
No disponible
Asunto(s)
Humanos , Encuestas de Atención de la Salud , Infecciones por Coronavirus/epidemiología , Neumonía Viral/epidemiología , Pandemias , Necesidades y Demandas de Servicios de Salud , Necesidades y Demandas de Servicios de Salud/estadística & datos numéricos , Cuidados Críticos/estadística & datos numéricos , Servicio de Anestesia en Hospital/provisión & distribución , EspañaRESUMEN
En diciembre del 2019, la Comisión Municipal de Salud y Sanidad de Wuhan (provincia de Hubei, China) informó de una serie de casos de neumonía de etiología desconocida. El 7 de enero del 2020, las autoridades chinas identificaron como agente causante del brote un nuevo tipo de virus de la familia Coronaviridae, denominado SARS-CoV-2. Desde entonces, se han notificado miles de casos con una diseminación global. Las infecciones en humanos provocan un amplio espectro clínico que va desde infección leve del tracto respiratorio superior, hasta síndrome de distrés respiratorio agudo grave y sepsis. No existe un tratamiento específico para SARS-CoV-2, motivo por lo que los aspectos fundamentales son establecer medidas adecuadas de prevención y el tratamiento de soporte y manejo de las complicaciones
In December 2019, the Wuhan Municipal Health and health Commission (Hubei Province, China) reported a series of cases of pneumonia of unknown etiology. On January 7, 2020, the Chinese authorities identified as a causative agent of the outbreak a new type of virus of the Coronaviridiae family, called SARS-CoV-2. Since then, thounsands of cases have been reported with global dissemination. Infections in humans cause a broad clinical spectrum ranging from mild upper respiratory tract infection, to severe acute respiratory distress syndrome and sepsis. There is not specific treatment for SARS-CoV-2, which is why the fundamental aspects are to establish adequate prevention measures and support treatment and management of complications
Asunto(s)
Humanos , Infecciones por Coronavirus/complicaciones , Coronavirus Relacionado al Síndrome Respiratorio Agudo Severo/patogenicidad , Coronavirus/patogenicidad , Procedimientos Quirúrgicos Operativos/métodos , Precauciones Universales/métodos , Atención Perioperativa/métodos , Coronavirus Relacionado al Síndrome Respiratorio Agudo Severo/clasificación , Transmisión de Enfermedad Infecciosa , Pautas de la Práctica en Medicina , Administración de la Seguridad/métodosRESUMEN
In December 2019, the Wuhan Municipal Health and health Commission (Hubei Province, China) reported a series of cases of pneumonia of unknown etiology. On January 7, 2020, the Chinese authorities identified as a causative agent of the outbreak a new type of virus of the Coronaviridiae family, called SARS-CoV-2. Since then, thounsands of cases have been reported with global dissemination. Infections in humans cause a broad clinical spectrum ranging from mild upper respiratory tract infection, to severe acute respiratory distress syndrome and sepsis. There is not specific treatment for SARS-CoV-2, which is why the fundamental aspects are to establish adequate prevention measures and support treatment and management of complications.
Asunto(s)
Betacoronavirus , Infecciones por Coronavirus/terapia , Atención Perioperativa/métodos , Neumonía Viral/terapia , COVID-19 , China , Infecciones por Coronavirus/diagnóstico , Infecciones por Coronavirus/epidemiología , Manejo de la Enfermedad , Humanos , Pandemias , Neumonía Viral/diagnóstico , Neumonía Viral/epidemiología , SARS-CoV-2RESUMEN
BACKGROUND: Donors after brain death (DBD) older than 60 years have become 46.8% of our current activity, with higher risk of renal discard rate (RDR). Assessment of kidney suitability requires complementary strategies: macroscopic evaluation, kidney biopsy score (KBS), and renal hemodynamic evaluation with the Pulsatile Perfusion Machine (PPM). METHODS: Descriptive, cross-sectional, comparative study of kidneys procured and RDR, comparing 3 time periods: 2000 to June 2004, when only KBS were used; July 2004 to 2008 (introduction of PPM and learning period); and 2009 to 2013 (experienced use of PPM). Transplantation criteria were KBS <3 and PPM renal resistance <0.4 mm Hg/mL/min and arterial renal flow >70 mL/min. RESULTS: Between 2000 and 2013, a 59.2% reduction in DBD kidneys was observed. However, older kidneys had an increase from 33.5% to 46.8%. The RDR had increased, comparing the first to the third period from 25.4% to 38.3%. However, the RDR was lower when kidneys were evaluated with PPM than those evaluated only with KBS and preserved in cold storage (CS) (21.4% versus 43.7%). There was a significant difference in cold ischemia time, because CS kidney was grafted before PPM. During the third period, more kidneys with KBS ≥4 were assigned to PPM. CONCLUSIONS: Notwithstanding the decrease in DBD-procured kidneys and the increase in older kidneys during last period, the use of PPM allowed low DR compared with CS. A bias in the results of PPM could be generated when kidneys with higher KBS were excluded from PPM. The use of KBS only to decide acceptance could preclude the use of an additional tool to evaluate suitability.
Asunto(s)
Muerte Encefálica/fisiopatología , Trasplante de Riñón , Preservación de Órganos , Flujo Pulsátil/fisiología , Factores de Edad , Anciano , Estudios Transversales , Criopreservación , Humanos , Persona de Mediana Edad , Donantes de Tejidos , Obtención de Tejidos y ÓrganosRESUMEN
A 17-year-old male suffered severe noncardiogenic pulmonary edema with arterial hypotension and acute renal insufficiency after withdrawal of a central venous catheter from the subclavian vein. The patient was in semirecumbent supine position with the head of the bed at a 40 degree angle. Resuscitation maneuvers, orotracheal intubation, and hemodynamic support were required. After 4 days in intensive care the patient had fully recovered. Fibrin tracts form around catheters and can create a way for air to enter a vein after catheter removal. The causes of pulmonary edema secondary to venous air embolism have been well studied: it seems that edema develops as a consequence of the sudden appearance of small air bubbles in pulmonary circulation, leading to an acute inflammatory response in pulmonary microvasculature. Experimental studies have shown that edema is associated with increased pulmonary vascular resistance that leads to pulmonary hypertension. Venous air embolism as a complication of central venous catheterization is too seldom detected and little stress is placed on this possibility in the care and removal of catheters.